Matches in DBpedia 2016-04 for { ?s ?p "Dr. Scholl's is a footwear and foot care brand owned by Bayer in the North and Latin American markets, and by Aurelius AG in its remaining markets worldwide. The brand in the North and Latin American markets was owned by Merck & Co. through its predecessor Schering-Plough until it was sold to Bayer on 1 October 2014. Aurelius AG bought the brand for all other markets from Reckitt Benckiser on 21 July 2014."@en }
Showing triples 1 to 4 of
4
with 100 triples per page.
- Dr._Scholls abstract "Dr. Scholl's is a footwear and foot care brand owned by Bayer in the North and Latin American markets, and by Aurelius AG in its remaining markets worldwide. The brand in the North and Latin American markets was owned by Merck & Co. through its predecessor Schering-Plough until it was sold to Bayer on 1 October 2014. Aurelius AG bought the brand for all other markets from Reckitt Benckiser on 21 July 2014.".
- Q17019662 abstract "Dr. Scholl's is a footwear and foot care brand owned by Bayer in the North and Latin American markets, and by Aurelius AG in its remaining markets worldwide. The brand in the North and Latin American markets was owned by Merck & Co. through its predecessor Schering-Plough until it was sold to Bayer on 1 October 2014. Aurelius AG bought the brand for all other markets from Reckitt Benckiser on 21 July 2014.".
- Dr._Scholls comment "Dr. Scholl's is a footwear and foot care brand owned by Bayer in the North and Latin American markets, and by Aurelius AG in its remaining markets worldwide. The brand in the North and Latin American markets was owned by Merck & Co. through its predecessor Schering-Plough until it was sold to Bayer on 1 October 2014. Aurelius AG bought the brand for all other markets from Reckitt Benckiser on 21 July 2014.".
- Q17019662 comment "Dr. Scholl's is a footwear and foot care brand owned by Bayer in the North and Latin American markets, and by Aurelius AG in its remaining markets worldwide. The brand in the North and Latin American markets was owned by Merck & Co. through its predecessor Schering-Plough until it was sold to Bayer on 1 October 2014. Aurelius AG bought the brand for all other markets from Reckitt Benckiser on 21 July 2014.".